InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001576280-25-000062 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-04 2025-03-01 GH Saia John G. CLO M - OptEx $0.00 +5,949 40.4K +17% $0
D 2025-03-04 2025-03-01 GH Saia John G. CLO F - Tax $42.55 -3,079 37.6K -8% -$131.0K
DM 2025-03-04 2025-03-01 GH Saia John G. CLO M - OptEx $0.00 -5,949 527 -92% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-01 M A 263 $0.00 40,650 D — —
2 Common Common Stock 2025-03-01 F D 3,079 $42.55 37,571 D — — (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
3 Common Common Stock 2025-03-01 M A 5,686 $0.00 40,387 D — —
4 Derivative Performance-Based Restricted Stock Units 2025-03-01 M D 5,686 $0.00 11,376 D $0.00 · — to — 5,686 Common Stock (F2) This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. The remaining 67% of the shares vest over the following two years, with 33% of the shares subject to the award vesting on January 1, 2026, and 34% of the shares subject to the award vesting on January 1, 2027. (F3) Not applicable for Restricted Stock Units.
5 Derivative Restricted Stock Units 2025-03-01 M D 263 $0.00 527 D $0.00 · — to — 263 Common Stock (F4) The restricted stock unit award was granted on November 2, 2021, and vested as to 25% of the shares subject to such award on September 1, 2022, the remaining 75% of the shares subject to such award vest in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. (F3) Not applicable for Restricted Stock Units.